Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
HCVC
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Instant Quantification of genetic modifications for Cell and Gene Therapies.
Gene therapy for advanced coronary artery disease. XyloCor Therapeutics is focused on improving the lives of patients through our…
Rejuvenate BioVenture round $19.5M · 3 mo ago • 51-200 employees
A gene therapy approach to treating chronic, age-related disease. Targeting the root causes of aging to create life-changing treatments for…
Seek LabsVenture round $2.7M · 22 mo ago • Founded 2024 • 201-500 employees • 1 role
Seek Labs pioneers sequence-agnostic CRISPR therapeutics and AI-driven molecular diagnostics — engineered to map, target, and address…
GenSight Biologics201-500 employees
On this page Key figures Home > Who we are > Company Our mission is to turn scientific advances in gene therapy into novel treatments for…
AgrageneVenture round $145k · 5 yr ago • Founded 2017 • 1-10 employees
Top of page A small team taking on a big pest problem. Developing innovative approaches to address major insect pest challenges on the farm…

Overview

Top of page Our Story Fuse Vectors was born from a shared vision to build better viral vectors for gene therapy. Drawing on their industry experience, Benjamin and Jordan took a bold leap to rethink how AAVs are made, and along the way, they were joined by Henrik, to help bring the vision to life.